Navigation Links
Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome
Date:11/20/2008

dical need for additional treatment options to combat resistant infections and is the first antibiotic in the dihydrofolate reductase (DHFR) selective inhibitor class to demonstrate efficacy against cSSSIs caused by MRSA. The DHFR class has been proven safe and effective in more than four decades of clinical use.

About Arpida

Arpida (SWX: ARPN) is a biopharmaceutical company headquartered in Reinach, Switzerland with operations in Switzerland and the United States. It focuses on the discovery, development and commercialization of novel drugs for the treatment of microbial infections. Arpida has a fully integrated platform for the discovery and development of drug candidates to address the increasing prevalence of resistance of bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA), to existing antibiotic therapies. Arpida is currently developing an iclaprim oral formulation as a step-down therapy after intravenous therapy. Apart from the flagship iclaprim program, Arpida has an innovative antifungal treatment in Phase III clinical development as well as several earlier-stage programs (AR-709 and AR-2474).

This press release contains specific forward-looking statements, e.g. statements including terms like believe, assume, expect or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of the company and those explicitly or implicitly presumed in these statements. Against the background of these uncertainties readers should not place undue reliance on forward-looking statements. The company assumes no responsibility to update forward-looking statements or to adapt them to future events or developments.

(i) Centers for Disease Control and Prevention Web site. Healthcare-Associated Methic
'/>"/>

SOURCE Arpida Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Arpida Invited to Present Data on Iclaprim at Scientific Conference
2. Arpida Provides Further Comments on the Pivotal Phase III Trials
3. Arpida Enrols First Patients in "Intravenous-to-Oral" Switch Trial With Oral Iclaprim
4. Arpida Completes Enrolment in Phase II "Intravenous-to-Oral" Switch Trial With Oral Iclaprim
5. Arpida Announces Review of Iclaprim NDA by FDA Advisory Committee in November 2008
6. Pivotal Phase III Data Confirm the Efficacy and Safety of Arpidas Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections
7. GeoVax Labs, Inc. Comments on Discontinuance of Mercks HIV Vaccine Trial
8. Pediatric Pulmonary Expert Comments on Study of Lung Transplants for Cystic Fibrosis
9. SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
10. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
11. Replidyne to Participate on Anti-infective Panel at RBC Capital Markets Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... NORTHBROOK, Ill. , May 29, 2015 /PRNewswire/ ... and MasterControl, a leading global provider of electronic ... announce a collaborative agreement which will leverage the ... industry with both quality system implementation and comprehensive ... Adding MasterControl,s EQMS capabilities to UL,s ...
(Date:5/29/2015)... Research and Markets ( http://www.researchandmarkets.com/research/64lx2w/north_america_mri ) has ... Market - Growth, Trends And Forecasts (2014 - 2019)" ... American MRI systems market is estimated to increase from ... by 2020 with a CAGR of 2.9% between 2014 ... the open system, closed system and the standing or ...
(Date:5/29/2015)... 2015 Actinobac Biomed, NovoPedics, Inc. and MentiNova, ... from Foundation Venture Capital Group (FVCG), have been selected ... part of the Start-Up Stadium and Company Presentation forums ... M. Golubieski . The annual convention, the ... held in Philadelphia in June. ...
Breaking Medicine Technology:UL and MasterControl collaborate to provide medical manufacturers full service QMS and Regulatory Submissions support 2UL and MasterControl collaborate to provide medical manufacturers full service QMS and Regulatory Submissions support 3North America MRI Market - Growth, Trends And Forecasts 2014-2019 with GE, Hitachi Medical, Philips Healthcare, Siemens Healthcare & Toshiba Medical Systems Dominating 2Foundation Venture Capital Group Portfolio Companies to be Highlighted at Bio International in June 2Foundation Venture Capital Group Portfolio Companies to be Highlighted at Bio International in June 3
... 25 The U.S. Food and Drug Administration is ... contains an active drug ingredient that can dangerously lower ... supplement for sexual enhancement. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ... TimeOut is labeled as "100% natural" and consumers may ...
... Aug. 25 Ambry Genetics, a global leader in ... Illumina HiSeq 2000 Next Generation Sequencing System as well ... System. Ambry Genetics has been an early adapter of ... as a Certified Service Provider. A team of scientists ...
Cached Medicine Technology:FDA Warns Consumers to Avoid TimeOut Capsules 2Ambry Genetics Announces the Addition of Illumina HiSeq 2000 and First 510(K) Approved BeadXpress® to Its Sequencing and Genotyping Capabilities 2
(Date:5/30/2015)... Luis Obispo, CA (PRWEB) May 30, 2015 ... Polk announced today that she is offering a free ... , The offer coincides with Disability Awareness Month, ... Happens . Industry members across the United States such ... a time to raise awareness about the possibility of ...
(Date:5/30/2015)... May 30, 2015 This year the ... with Pulmonary Horizons to offer one of the most ... and discuss successful practices to diagnose, treat and manage ... Pulmonary Horizons Conference is Interaction with Multidisciplinary ... the Overall Needs of Patients with COPD," said Brian ...
(Date:5/30/2015)... Venus Viva has proven to work in ... wrinkles, stretch marks, pigmentation irregularities, and uneven texture when ... F. Victor Rueckl of Lakes Dermatology in Las Vegas ... Vegas. This body image solution combines NanoFractional Radio Frequency ... proven results through a skin heating process that offers ...
(Date:5/29/2015)... 30, 2015 “In the current ... and federal regulations, we provide education that will ... who are suffering from pain, within the boundaries ... MD, professor of rehabilitation medicine and President/Medical Director ... Park, Kansas. , A new flight of PAINWeekEnd ...
(Date:5/29/2015)... What does community do? , According to a ... to plant gardens, to teach young people, to laugh, ... issues. Community invites everyone to help improve lives for ... Does" was commissioned by The Denver Foundation, the largest ... the foundation’s Annual Celebration in May. At just over ...
Breaking Medicine News(10 mins):Health News:San Luis Obispo Insurance Agent Susan Polk Offering Complementary Insurance Analysis In Honor Of Disability Awareness Month 2Health News:Pulmonary Horizons 2nd Annual COPD Conference Miami Hilton Downtown, July 17-19, 2015 Patient Centered Cross-Continuum Education to Improve the Care of Patients with COPD 2Health News:Pulmonary Horizons 2nd Annual COPD Conference Miami Hilton Downtown, July 17-19, 2015 Patient Centered Cross-Continuum Education to Improve the Care of Patients with COPD 3Health News:Announcing Ground-Breaking Technology for Anti-Aging, FDA Approved, Venus Viva. 2Health News:Announcing Ground-Breaking Technology for Anti-Aging, FDA Approved, Venus Viva. 3Health News:PAINWeekEnd Kansas City: Pain Management CME for the Main Street Practitioner 2Health News:What Community Does: A New Video from The Denver Foundation 2
... ZEELAND, Mich., Dec. 19 Herman Miller, Inc.,announced ... Inc.,a Seattle-based manufacturer of healthcare furnishings. The transaction ... the conclusion of due,diligence. Terms of the transaction ... of healthcare furnishings, with an emphasis,on seating products ...
... Delta Dental of Illinois has made,a ... Illinois at Chicago,College of Dentistry to modernize ... are complete, the clinic will be named ... Clinic., (Photo: http://www.newscom.com/cgi-bin/prnh/20071219/AQW128 ), ...
... SCHAUMBURG, Ill., Dec. 19 The American,Veterinary Medical ... the Veterinary Workforce Grant Program (VWGP) as part ... program will help ensure an,adequate supply of public ... "The Farm Bill is vitally important to rural ...
... new molecular pathway that appears to be involved in ... 100 million people around the world and is caused ... Blocking this pathway could be a treatment for the ... failure. The research teams findings will appear in ...
... a big impact on behavior, studies show , , WEDNESDAY, Dec. ... its 1 trillion cells, looking for perhaps only one or ... a trio of new studies says. , The research, conducted ... Nature , could rewrite the textbooks on just how ...
... Researchers here have figured out a way to use ... a new drug combination actually is against some forms of ... looked at ATLL, adult T-cell lymphoma and leukemia, a form ... disease,s progress, and where the patients, prognosis is generally poor. ...
Cached Medicine News:Health News:Herman Miller, Inc., Announces Strategic Acquisition of Brandrud Furniture, Inc. to Expand Its Product Offerings and Competitive Position in the Healthcare Furnishings Sector 2Health News:Herman Miller, Inc., Announces Strategic Acquisition of Brandrud Furniture, Inc. to Expand Its Product Offerings and Competitive Position in the Healthcare Furnishings Sector 3Health News:Delta Dental of Illinois Announces Major Gift to University of Illinois at Chicago College of Dentistry 2Health News:AVMA Lauds Senators for Approving 2007 Farm Bill Legislation that Includes the Veterinary Workforce Grant Program 2Health News:Receptor protein appears to be key in breakdown of kidney filtration 2Health News:Receptor protein appears to be key in breakdown of kidney filtration 3Health News:Brain Cells More Powerful Than You Think 2Health News:Brain Cells More Powerful Than You Think 3Health News:Brain Cells More Powerful Than You Think 4Health News:Firefly genes allow testing of new therapy against lymphoma 2Health News:Firefly genes allow testing of new therapy against lymphoma 3
... Built-in, motor-driven internal calibration mass for ... Self-Calibration when temperature change detected and ... weighing parameters, plug-in peripherals, and easy ... this balance series highly accurate and ...
Can download data from your A&D balance directly to your PC saving time and reducing the chances of manually recording the wrong weighing data; 60 month warranty; automatic adjustable environment set...
... DNA sequencing reagents including linear polyacrylamide ... cyanine-based infrared dyes- coupled with online denaturation. ... meaningful raw data, and higher-quality final analyses. ... 8800 to resolve complex sequences, filling in ...
... 3100 system offers continuous, unattended operation ... separation and detection, and data analysis. ... and importing sample information, the operator ... Run command. The instrument requires no ...
Medicine Products: